2013

List of publications

  • Bire S, Ley D, Casteret S, Mermod N, Bigot Y, Rouleux-Bonnin F. Optimization of the piggyBac transposon using mRNA and insulators: Toward a more reliable gene delivery system. PLoS One. 2013 Dec 3;8(12):e82559. - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Sulpice L, Rayar M, Desille M, Turlin B, Fautrel A, Boucher E, Llamas-Gutierrez F, Meunier B, Boudjema K, Clément B, Coulouarn C. Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma. Hepatology. 2013 Dec;58(6):1992-2000.
  • Rouault-Pierre K, Lopez-Onieva L, Foster K, Anjos-Afonso F, Lamrissi-Garcia I, Serrano-Sanchez M, Mitter R, Ivanovic Z, de Verneuil H, Gribben J, Taussig D, Rezvani HR, Bonnet D*, F Mazurier*. HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress. Cell Stem Cell. 2013 Nov 7;13(5):549-63. *equal contributors - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Bourgeais J, Gouilleux-Gruart V, Gouilleux F. Oxidative metabolism in Cancer: a STAT affair ? JAKSTAT. 2013 Oct 1;2(4):e25764. (review) - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Monderer D, Luseau A, Bellec A, David E, Ponsolle S, Saiagh S, Bercegeay S, Piloquet P, Denis D, Lodé L, Rédini F, Biger M, Heymann D, Heymann MF, Le Bot R, Gouin F, Blanchard F. New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance. Lab Invest. 2013 Oct;93(10):1100-14. - (MNT team: INSERM UMR 957 - Nantes)
  • Bialoszewska A, Baychelier F, Niderla-Bielinska J,Czop A, Debre P, Vieillard V , Kieda C. and Malejczyk J. Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes. Cell Immunol. 2013 Sep-Oct;285(1-2):6-9. - (MNT Team: CNRS UPR4301 CBM - Orléans)
  • Bire S, Gosset D, Jégot G, Midoux P, Pichon C, Rouleux-Bonnin F. Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition. BMC Biotechnol. 2013 Sep 26;13:75. - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Skrzypek K, Tertil M, Golda S, Ciesla M, Weglarczyk K, Collet G, Guichard A, Kozakowska M, Boczkowski J, Was H, Gil T, Kuzdzal J, Muchova L, Vitek L, Loboda A, Jozkowicz A, Kieda C, Dulak J.. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid Redox Signal. 2013 Sep 1;19(7):644-60. - (MNT Team: CNRS UPR4301 CBM - Orléans)
  • Rédini F, Odri G, Picarda G, Gaspar N, Heymann MF, Corradini N, Heymann D. Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma? Expert Opin Emerg Drugs. 2013 Sep;18(3):339-52. - (MNT team: INSERM UMR 957 - Nantes)
  • Pracht M, Edeline J, Lepareur N, Lenoir L, Ardisson V, Clement B, Raoul JL, Audrain O, Boucher E, Garin E. In vitro demonstration of synergy/additivity between (188)rhenium and sorafenib on hepatoma lines: preliminary results. Anticancer Res. 2013 Sep;33(9):3871-7.
  • Dzieran J et al. Comparative analysis of TGF‐β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines. PLoS One. 2013 Aug 22;8(8):e72252.
  • Collet G, Grillon C, Nadim M and Kieda C Trojan horse at cellular level for tumor gene therapies. Gene. 2013 Aug 10;525(2):208-16. - (MNT Team: CNRS UPR4301 CBM - Orléans)
  • Edeline J et al. Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? Ann Surg Oncol. 2013 Aug;20(8):2518-25.
  • Matejuk A., Collet G., Nadim M., Grillon C. and Kieda C. MicroRNAs and Tumor Vasculature Normalization : Impact on Anti-Tumor Immune Response. Arch Immunol Ther Exp (Warsz). 2013 Aug;61(4):285-99. (MNT Team: CNRS UPR4301 CBM - Orléans)
  • Vignon C, Debeissat C, Georget MT, Bouscary D, Gyan E, Rosset P, Herault O. Flow cytometric quantification of all phases of the cell cycle and apoptosis in a two-color fluorescence plot. PLoS One. 2013 Jul 30;8(7):e68425. - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Edeline J et al. Boosted selective internal radiation therapy with 90Y‐loaded glass microspheres (B‐SIRT) for hepatocellular carcinoma patients: a new personalized promising concept. Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1057-68.
  • Kieda, C. El Hafny-Rahbi, B. Collet, G. Lamerant-Fayel, N. Grillon, C. Guichard, A. Dulak, J. Jozkowicz, A. Kotlinowski, J. Fylaktakidou, K. C. Vidal, A. Auzeloux, P. Miot-Noirault, E. Beloeil, J. C. Lehn and J. M. Nicolau, C. Stable tumor vessel normalization with pO increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment. J Mol Med (Berl). 2013 Jul;91(7):883-99. - (MNT Team: CNRS UPR4301 CBM - Orléans)
  • Georges S, Chesneau J, Hervouet S, Taurelle J, Gouin F, Redini F, Padrines M, Heymann D, Fortun Y, Verrecchia F. A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis. Eur J Cancer. 2013 Jun;49(9):2253-63. - (MNT team: INSERM UMR 957 - Nantes)
  • Chiron D, Maïga S, Surget S, Descamps G, Gomez-Bougie P, Traore S, Robillard N, Moreau P, Le Gouill S, Bataille R, Amiot M and Pellat-Deceunynck C. Autocrine IGF1 and SCF but not IL6 support self-renewal of human myeloma cells. Blood Cancer J. 2013 Jun 7;3:e120. CGO is thanked - (MNT team: INSERM UMR892/ CNRS U6299 Eq.10 - Nantes)
  • Heymann D, Rédini F. Targeted therapies for bone sarcomas. Bonekey Rep. 2013 Jul 17;2:378. - (MNT team: INSERM UMR 957 - Nantes)
  • Agasse F, Xapelli S, Coronas V, Christiansen SH, Rosa AI, Sardá-Arroyo L, Santos T, Ferreira R, Schitine C, Harnois T, Bourmeyster N, Bragança J, Bernardino L, Malva JO, Woldbye DP. Galanin promotes neuronal differentiation in murine subventricular zone cell cultures. Stem Cells Dev. 2013 Jun 1;22(11):1693-708. - (MNT team: CNRS ERL 7368 - Poitiers)
  • Ando K, Heymann MF, Stresing V, Mori K, Rédini F, Heymann D. Current therapeutic strategies and novel approaches in osteosarcoma. Cancers (Basel). 2013 May 24;5(2):591-616. - (MNT team: INSERM UMR 957 - Nantes)
  • Talbot J, Brion R, Picarda G, Amiaud J, Chesneau J, Bougras G, Stresing V, Tirode F, Heymann D, Redini F, Verrecchia F. Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis. Biochim Biophys Acta. 2013 Apr;1832(4):553-64. - (MNT team: INSERM UMR 957 - Nantes)
  • Meyer C, Dzieran J, Liu Y, Schindler F, Munker S, Müller A, Coulouarn C, Dooley S. Distinct dedifferentiation processes affect caveolin‐1 expression in hepatocytes. Cell Commun Signal. 2013 Jan 22;11(1):6.
  • Picarda G, Matous E, Amiaud J, Charrier C, Lamoureux f, Heymann MF, Tirode F, Pitard B, Trichet V, Heymann D, F Redini. Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoima by inhibiting RANKL. J Bone Oncol, Volume 2, Issue 3, September 2013, Pages 95–104 - (MNT team: INSERM UMR 957 - Nantes)
  • Kieda, C. Heterogeneity of endothelial cells--role in vessel specialization and cooperation in vasculogenic mimicry. Postepy Biochem. 2013;59(4):372-8. - (MNT Team: CNRS UPR4301 CBM - Orléans)
  • Pracht M, Edeline J, Lenoir L, Latournerie M, Mesbah H, Audrain O, Rolland Y, Clément B, Raoul JL, Garin E, Boucher E. Lobar hepatocellular carcinoma with ipsilateral portal vein tumor thrombosis treated with yttrium‐90 glass microsphere radioembolization: preliminary results. Int J Hepatol. 2013;2013:827649.